Overview
Stemline Therapeutics develops and manufactures pharmaceutical treatments, including therapies for blood cancers and related conditions[2]. Founded in 2003[3], the company maintains its primary United States headquarters at 750 Lexington Avenue, 4th Floor, New York, NY 10022[1]. The company operates within the pharmaceutical sector, focusing on therapeutic development and manufacturing for hematologic malignancies and associated medical conditions[2].
The company's own site places it in New York: Company lists primary US address at 750 Lexington Avenue, 4th Floor, New York, NY 10022 for adverse events, product complaints, and medical . [1]
Leadership & org chart
Brinda BanerjeeChief Information Officer
John MeckfesselSenior Vice President, Head of Commercial and Market Access
Matt BurkeVice President, Global Head of R&D CMC
Matthijs Van MeerveldAssociate Vice President, Global Head of Patient Advocacy and Policy
Uğur YazganVice President, Head of Global Marketing and Commercial Excellence Oncology2 alumniAlumni
- John MeckfesselVice President, Head of Marketing
- Matt BurkeVice President, Technical Operations & Product Development
Something wrong or missing? Send an update. Fixed within 24 hours.